Abnormal finding on pap, cytologic evidence of malignancy; Cytologic evidence of malignancy on cervical papanicolaou smear. ICD-10-CM Diagnosis Code R87.614. Cytologic evidence of malignancy on smear of cervix. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code.
Abnormal finding on pap, cytologic evidence of malignancy; Cytologic evidence of malignancy on cervical papanicolaou smear. ICD-10-CM Diagnosis Code R87.614. Cytologic evidence of malignancy on smear of cervix. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code.
Oct 01, 2021 · R87.619 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Unsp abnormal cytolog findings in specmn from cervix uteri The 2022 edition of ICD-10-CM …
The ICD-10-CM code R87.619 might also be used to specify conditions or terms like abnormal cervical papanicolaou smear, abnormal cervical papanicolaou smear with positive human papillomavirus deoxyribonucleic acid test, abnormal cervical smear, atypical endocervical cells on cervical papanicolaou smear, cannot exclude glandular neoplasia on cervical smear , cervical …
R87.619 is a billable diagnosis code used to specify a medical diagnosis of unspecified abnormal cytological findings in specimens from cervix uteri. The code R87.619 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code R87.619 might also be used to specify conditions or terms like abnormal cervical papanicolaou smear, abnormal cervical papanicolaou smear with positive human papillomavirus deoxyribonucleic acid test, abnormal cervical smear, atypical endocervical cells on cervical papanicolaou smear, cannot exclude glandular neoplasia on cervical smear , cervical smear - atrophic changes, etc.#N#The code R87.619 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.#N#The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.#N#Unspecified diagnosis codes like R87.619 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R87.619 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer.
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
Unspecified diagnosis codes like R87.619 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition.
The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.
Cancer found early may be easier to treat. Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix.